A ngiotensin II (Ang II) exerts a remarkable diversity of physiological actions. In addition to its hemodynamic effects, Ang II has been implicated in the regulation of cell growth and differentiation. [1] [2] [3] Two Ang II receptor subtypes have been defined, which are designated as AT 1 and AT 2 receptors. 4 Most of the known hemodynamic and the growthpromoting effects of Ang II are mediated by AT 1 receptors. 5 Considerably less is known about the physiological role of AT 2 receptors. Recent evidence suggests an involvement of AT 2 receptors in development and apoptosis in various tissues 6 -9 as well as regeneration after injury. 10 -12 Although the signaling cascade of the AT 1 receptor is well characterized, the signaling of the AT 2 remains a matter of great debate. Overall, diverse putative AT 2 receptor signaling pathways are discussed, which include activation of serine/ threonine phosphatase PP2A and subsequent opening of the delayed rectifier K ϩ -channel, activation of cytosolic phosphotyrosine phosphatases which may lead to closing of the T-type Ca 2ϩ channel, inactivation of mitogen-activated protein kinase, presumably through PP2A and other phosphotyrosine phosphatases, and the activation of phospholipase A 2 (for a review, see de Gasparo et al 5 ) . A hallmark of AT 2 signaling appears to be the activation of phosphatases to inhibit phosphorylation steps in, eg, growth signaling. 13, 14 Recently, ceramide, which is also linked to phosphatase activation, was proposed to be the second messenger in AT 2 receptor-mediated apoptosis. 15, 16 However, little is known concerning target genes of the AT 2 -signaling cascade. The AT 2 receptor may exert its growth-modulating actions on various levels including the modulation of the signaling of other receptors 17 and the activity of growth and transcription factors, as well as remodeling of the extracellular matrix. To search for downstream targets that mediate the growthmodulating properties of AT 2 receptors, we used differential mRNA display 18 to identify genes regulated after stimulation of AT 2 receptors under conditions in which the known antiproliferative actions of this receptor subtype are well established.
Medium supplemented with 100U/100 g/mL penicillin/streptomycin, 2 mmol/L L-glutamine (Gibco BRL), 5% heat inactivated fetal calf serum (Biowhitaker), 10% heat inactivated donor horse serum (Bioconcept) as previously described. 19 Rat coronary endothelial cells (CECs) were isolated from male Wistar rats and characterized and cultured as previously described. 3 To achieve quiescence, PC12w cells and CECs were serum-deprived for 48 hours before the experiment as previously described. 3, 19 PC12w cells were used from passages 8 to 15, and CECs were used exclusively at passage 2.
Angiotensin Receptor Binding Studies
The presence of angiotensin receptors was verified by binding studies as previously described. 3, 19 
Experimental Protocol
For the initial differential mRNA display, quiescent PC12w cells were stimulated with epidermal growth factor (EGF, 50ng/mL) in the presence or absence of Ang II (10 Ϫ7 mol/L). Total RNA was extracted 1 and 6 hours after stimulation of the cells while vehicletreated cells served as controls.
To verify differential expression of the clones of interest, PC12w cells were stimulated in subsequent experiments with either EGF (50 ng/mL) or Ang II (10 Ϫ7 mol/L) alone or in combination, and in the presence or absence of the specific AT 1 receptor antagonist losartan (10 Ϫ5 mol/L), and the selective AT 2 receptor antagonist PD123177 (10 Ϫ6 mol/L). Gene expression was investigated at time points 1, 3, and 6 hours after stimulation of cells.
In a second set of experiments, we investigated the gene expression of one of the clones isolated, Zfhep, in rat CECs. The experimental protocol for stimulation of CECs was identical to the protocol used for our studies on the growth-modulating actions of AT 1 and AT 2 receptors in these cells. 3 In brief, CECs were serumdeprived for 48 hours and then stimulated with Ang II (10 Ϫ7 mol/L) in the presence or absence of losartan (10 Ϫ5 mol/L) and PD123177 (10 Ϫ6 mol/L). In a second set of experiments, quiescent CECs were stimulated to proliferate for 16 to 20 hours by the addition of 25 ng/mL basic fibroblast growth factor (bFGF) before stimulation with Ang II in the presence or absence of the respective antagonists. Total RNA was extracted 1, 3, and 6 hours after stimulation of the cells with Ang IIϮantagonists.
Differential mRNA Display
Total RNA was extracted according to the protocol by Chomczynski and Sacchi 20 and dissolved in water at a final concentration of 0.2 g/L. First-strand synthesis (5 g total RNA) was performed with the Superscript Preamplification Kit (Gibco BRL) by using OligodT [12] [13] [14] [15] [16] [17] [18] oligonucleotides. Quality of reverse-transcribed cDNA (absence of contamination with genomic DNA and equality of cDNA amount) was verified by reverse-transcription-polymerase chain reaction (RT-PCR) by using intron spanning primers for ␤-actin (Clontech). Second-strand cDNA synthesis was initiated by arbitrary priming with a modified primer based on the method described by Welsh et al, 18 in which the original primer KZ (5Ј-CCCATGTGTACGCGTGTGGG-3Ј) was modified by the insertion of a PstI restriction site, resulting in the primer AZ-PstI (5Ј-CCCTGCAGTGTACGCGTGTGGG-3Ј). In a final reaction volume of 100 L, PCR was performed by using 200 mol/L of each dNTP, 3 mmol/L of MgCl 2 , 400 nmol/L of each primer, and 2.5 U of Taq polymerase (Gibco BRL), corresponding PCR buffer, and 10 Ci of ␣-32 P-dCTP. The PCR temperature profile used was 94°C (5 minutes) hot start, low stringency annealing at 40°C (5 minutes), and primer extension at 72°C (5 minutes) followed by 10 cycles of 94°C (1 minute), 50°C (1 minute), 72°C (1 minute), and 30 cycles of 94°C (1 minute), 60°C (1 minute), 72°C (1 minute), and 5 minutes at 72°C to ensure double-stranded cDNA.
Gel Electrophoresis
Labeled products were displayed in duplicate on a 6% denaturing polyacrylamide sequencing gel, electrophoresed at 1500 V until the xylene cyanol dye had reached the bottom of the gel, and exposed to a x-ray film (Kodak) to visualize bands. Unique bands were excised, eluted from the gel, and re-amplified with the Az-PstI primer. PCR conditions for re-amplification were as follows: In a final reaction volume of 100 L, PCR was performed by using 200 mol/L of each dNTP, 2.5 mmol/L of MgCl 2 , 200 nmol/L of each primer, and 2.5 U of Taq polymerase plus corresponding PCR buffer. The PCR temperature profile used was 94°C (5 minutes) hot start, followed by 30 cycles of 94°C (1 minute), 60°C (1 minute), 72°C (1 minute), and 5 minutes at 72°C to ensure double-stranded cDNA. Isolated cDNA fragments were digested with PstI, subcloned into the multiplecloning site of the pGem-4z plasmid (Promega), and transformed into XL1-blue high-efficiency Escherichia coli host cells (Stratagene). Differential expression of the clones of interest was verified by Northern blot hybridization and/or RT-PCR.
Sequence Analysis
All subcloned cDNA fragments were sequenced with the M13/pUC forward primer and the ABI Prism Ready Reaction Dideoxy Terminator Cycle Sequencing Kit (Perkin Elmer) following the manufacturer's protocol. The sequencing reaction products were resolved on an ABI PRISM Automated DNA Sequencer (ABI 377, Applied Biosystems). The differentially expressed cDNA clones were compared with a non-redundant nucleotide sequence database that includes sequences from the Brookhaven Protein Data Bank, GenBank, GenBank updates, European Molecular Biology Laboratories, and updates with the BLAST and the FastA algorithm at the National Center for Biotechnology Information. 21 
Northern Blot Analysis
RNA (10 g/lane) was separated by electrophoresis on a 1.2% agarose, 2.2 mol/L formaldehyde gels and transferred onto a nylon membrane (Amersham, Hybond N). Hybridization was performed by using QuickHyb hybridization solution (Stratagene) and 1 to 5ϫ10 7 cpm of 32 P-labeled PstI-cut fragments of the cloned rat cDNAs. Filters were washed at 65°C with increasing stringency with 2ϫSSC/ 0.1%SDS up to 0.1ϫSSC/0.1%SDS before exposure to x-ray film at Ϫ70°C. Filters were stripped and rehybridized to a probe for ribosomal RNA or a 0.8-kilobase PstI fragment for glyceraldehyde-3-phosphate dehydrogenase as a control for gel loading and transfer.
RT-PCR
First-strand synthesis (5 g total RNA) was performed with the Superscript Preamplification Kit (Gibco BRL) by using Oligo-dT [12] [13] [14] [15] [16] [17] [18] oligonucleotides. Quality of reverse-transcribed cDNA (absence of contamination with genomic DNA and equality of cDNA amount) was verified by RT-PCR by using intron spanning primers for ␤-actin (Clontech). All PCR reactions were performed with standard conditions unless otherwise stated. The PCR temperature profile used was 94°C (5 minutes) hot start, followed by 30 cycles of 94°C (1 minute), 60°C (1 minute), 72°C (1 minute), and 5 minutes at 72°C. Optimal PCR conditions were established by determining the relationship between signal strength and number of PCR cycles for Zfhep (nϭ3 for each condition) and ␤-actin, and saturation of PCR reaction was reached at more than 33 PCR cycles for ␤-actin whereas Zfhep mRNA was detectable for the first time after 30 cycles (data not shown). Amplimers for the ␤-actin control were verified for the correct size (1128 bp) to ensure quality of cDNA and lack of contamination with genomic DNA. Identity of the Zfhep PCR products was verified by hybridization to the original clone isolated from the differential mRNA display by using standard protocols for slot blots after RT-PCR. Autoradiographic signals were densitometrically quantified using NIH Image.
Oligonucleotides
Oligonucleotides used for RT-PCR cDNA were ␤-actin sense: 4Ј-ATGGATGATGATATCGCCGCG-3Ј, ␤-actin antisense: 5Ј-CTAGAAGCATTTGCGGTGGACGATGGAGGGGCC-3Ј, Zfhep sense: 5Ј-CACATTAAGTACCGCCATGAGA, and Zfhep antisense: 5Ј-GTTGTGCCATCCTGATCAACTA.
Statistics
All experiments were performed in at least 4 independent experiments from 3 individual isolations of CECs or individual subcultures of PC12w, respectively. Statistical analysis of differential gene expression was performed on the data from densitometric analysis by using one-way ANOVA followed by appropriate post hoc tests.
Results

Differential mRNA Display
In the initial differential mRNA display, the gene expression in PC12w cells after stimulation with 50 ng/mL EGF was compared with cells stimulated with 50 ng/mL EGF plus Ang II (10 Ϫ7 mol/L) at 1 and 6 hours. Quiescent cells served as controls to account for constitutive gene expression. The band pattern of the display after amplification of the respective cDNAs with the AzPstI-primer revealed 9 differentially amplified bands (200 to 450 bp), of which most were found to be different after 6 hours and three were verified with Northern blots. In addition to these, we isolated one fragment that was markedly expressed after 1 hour in the EGF group. This clone was 69% homologous to human insulin-like growth factor-2 (IGF-2) and showed a marked differential expression on the initial Northern blot with a size of Ϸ900 bp that is comparable to the reported size for IGF-2 ( Figure 1 ). However, a differential expression of this clone was only observed between quiescent PC12w cells and EGF-treated cells, an effect that was not affected by Ang II. Sequence analysis of three of the clones differentially displayed in the 6-hour group revealed for clone 2: 100% identity to U52584 (rat Zfhep-1/2) in 224-bp overlap, for clone 3: 100% identity to D43778 (rat angiotensin AT 2 receptor) in a 198-bp overlap, and for clone 4: 85% identity to Y00168 (rat fibroblast tropomyosin 4) in 135-bp overlap. The sequence of clone 2 (Zfhep-1/2) obtained from the differential mRNA display, as well as its relation to the known open reading frame, is presented in Figure 2 . Northern blot analysis with the total RNA from the initial experiment for the differential display RT-PCR (DDRT-PCR) confirmed a differential mRNA expression for Zfhep after stimulation with EGFϮAng II at 1 and 6 hours after stimulation (Figure 1 (Figure 1 ).
Differential Expression of Zfhep in PC12w Cells
Zfhep 22 hybridized to a mRNA of approximately 3.4 to 3.5 kb, which is in accordance with the reported size for the homologous mRNA reported for Zfhep-1 (3403bp). The expression level of this clone on mRNA level was very low, but a regulation of the Zfhep mRNA was clearly detectable (Figure 1 ) with a rapid induction of Zfhep 1 hour after stimulation with EGF (50 ng/mL) Ϯ Ang II (10 Ϫ7 mol/L). Six hours after stimulation, Zfhep mRNA was still detectable in EGF-treated cells, but no longer present in EGFϩAng IItreated cells (Figure 1) , thus confirming the initial mRNA display which revealed downregulation of this band by Ang II 6 hours after stimulation. This initial experiment indicated that Ang II may regulate growth factor-induced Zfhep expression in PC12w cells; however, it did not address whether Ang II via the AT 2 receptor could directly regulate Zfhep in the absence of EGF. Therefore, subsequent experiments were performed in which quiescent PC12w cells were stimulated with Ang II (10 Ϫ7 mol/L) in the presence or absence of the specific AT 2 receptor antagonist PD123177 (10 Ϫ6 mol/L) over a course of 1 to 24 hours. The AT 1 receptor antagonist losartan was not tested in these experiments because PC12w cells in the passages used express exclusively AT 2 receptors. 19 As shown in Figure 3 , no Zfhep mRNA expression was detected in quiescent PC12w cells. Treatment with Ang II resulted in a rapid induction of Zfhep mRNA expression, an effect that was abolished in the presence of PD123177 (Figure 3 ). Three hours after stimulation, Zfhep expression was no longer detectable throughout the course of the experiment.
Because the basal expression level of Zfhep was very low and difficult to quantify using Northern blot analysis, we designed primers based on the published sequence and used semi-quantitative RT-PCR for subsequent experiments. These experiments were also performed to verify that the isolated clone was indeed Zfhep, because the PCR products were hybridized to the original clone isolated from the differential mRNA display by slot blot hybridization. In these experiments, a basal expression of Zfhep in quiescent PC12w cells was detectable by using RT-PCR. This expression was enhanced 1 hour and 3 hours after stimulation with Ang II (10 Ϫ7 Figure 1 . a, Initial Northern blot for the isolated and sub-cloned DDRT-PCR fragments from initial experiment in PC12w stimulated with EGFϮAng II. PCR product 1: 68% identity to IGF-2; PCR product 2: 100% identity to Zfhep1/2; PCR product 3: 100% identity to rat AT 2 receptor. 28S RNA served as control for equal loading of lanes. b, Differential expression of the clones presented as graph showing the ratio between the clones and 28S rRNA after densitometric quantification by using NIH Image. Zfhep and the AT 2 receptor were down-regulated by Ang II at 6 hours (lane 5) confirming the initial differential display. mol/L), an effect that was abolished in the presence of the AT 2 receptor antagonist PD123177 (10 Ϫ6 mol/L; Figure 3b ).
Induction of Zfhep mRNA Expression in CEC by AT 2 -Receptor Stimulation
In a second set of experiments, we investigated the gene expression of Zfhep in rat CECs to evaluate the AT 2 receptorrelated gene expression in cells of vascular origin. In addition, these cells have been shown to express both Ang II receptors, 3 
Discussion
Apart from its cardiovascular effects, the control of cellular proliferation, differentiation, and apoptosis appears to constitute major actions of Ang II. Recent studies implicate a differential role of both AT 1 and AT 2 receptors in these processes (for review, see de Gasparo 5 ). Growth stimulatory effects induced by Ang II are usually associated with the stimulation of AT 1 receptors, 2,23 whereas AT 2 receptors have been shown to inhibit the proliferation of various cell types in vitro 3, 19, 24 and in vivo 1, 25 and to induce morphological differentiation in cells of neuronal origin. 26 Furthermore the AT 2 receptor may act in a pro-apoptotic manner 9, 27 and has been connected with regenerative processes after tissue injury; 10, 12 both by its biological activity and its clear upregulation during embryogenesis 28 and after injury. 11 Using differential mRNA display, we isolated differentially expressed genes after stimulation of AT 2 receptors to further characterize downstream events of AT 2 signaling and to identify potential genes that are involved in the AT 2 -induced antigrowth actions. From the initial nine differentially displayed PCR products after stimulation of PC12w cells with EGFϮAng II, three genes were successfully confirmed by Northern blot.
Although each of the clones were of potential interest, we prioritized the characterization of Zfhep 22 , because it appeared to directly relate to the proposed function of the AT 2 receptor. Zfhep belongs to the zfh family of Drosophila genes that are required for differentiation of the central nervous system and in the regulation of cell fate. 29, 30 In addition, studies on the vertebrate homologue, ZEB, have extended the findings to a role in myogenesis, skeletal development and early T-cell development. 31, 32 Our initial experimental design for differential mRNA display (EGF versus EGFϩAng II versus control at 1 and 6 hours) was chosen for two reasons: (1) to limit the number of potential genes of interest to a manageable level, and (2) to capture genes involved in the events preceding the growthinhibiting and differentiation-promoting actions of the AT 2 described in these cells. 19 In the course of the characterization of Zfhep, we verified the involvement of AT 2 receptor activation in Zfhep expression in the absence of EGF, conditions in which the AT 2 receptor is known to induce differentiation of PC12w cells. 19 In quiescent PC12w cells, Ang II transiently induced the expression of Zfhep, 1 and 3 hours after stimulation, an effect that was AT 2 -specific because it was abolished by the AT 2 antagonist PD123177. Studies were then extended to CECs to determine whether the observed induction of Zfhep mRNA was specific to neuronal cells that undergo differentiation, or whether this induction can also be observed in cells of vascular origin. This was particularly interesting as PC12w cells exclusively express AT 2 receptors whereas CECs express both AT 1 and AT 2 receptors and respond differently to Ang II depending on which receptor subtype is amenable. 3 Our results confirm that the AT 2 receptor induces Zfhep in CECs as well. However, an effect of Ang II on CECs was only detected when the AT 1 receptors were blocked by losartan. The finding that simultaneous stimulation of both receptors by Ang II was ineffective on Zfhep expression suggests that the AT 1 receptor does not stimulate Zfhep transcription but downregulates AT 2 -induced Zfhep mRNA expression. In all previous reports, the Ang II-mediated induction of transcription factors was attributed to the AT 1 receptor, 33, 34 an effect that was unopposed by the AT 2 receptor. 35 To our knowledge, this is the first report on the induction of a transcription factor via the AT 2 receptor that is opposed by the AT 1 receptor. In our opinion, Zfhep represents a suitable marker for the study of AT 2 receptor activation and the subsequent elucidation of signaling events involved in the regulation of cell growth and differentiation. For example, a yeast-2-hybrid screen revealed an interaction between the third intracellular loop of the AT 2 receptor and a member of the EGF receptor family, ErbB3, as part of a novel signaling mechanism for the AT 2 receptor-mediated inhibition of cell growth. 36 Our initial experiment for the differential mRNA display examined such an interaction, the influence of AT 2 receptor activation on EGF-induced growth in PC12w, which ultimately led to the discovery of Zfhep. Therefore, Zfhep may represent an important link between early events in receptor-receptorcross talk, such as AT 2 -ErbB3, and downstream target genes involved in cellular growth and differentiation. The question remains regarding the biological role of Zfhep within AT 2 -mediated effects. The presence of a homoeobox domain implies a putative action on differentiation genes. Recent studies showed that the mouse homologue ZEB downmodulates the activity of transcriptional activators involved in cell differentiation such as c-myb, NF-B p65, MEF2C, ITF-1, and myoD. 37 Since differentiation requires positive and negative regulation of transcriptional activators to ensure a proper temporospatial pattern of gene expression, it was postulated that ZEB is involved in the orchestration of differentiation events. 37 Similarly, the AT 2 receptor has been proposed to participate in events leading to cell differentiation and/or apoptosis. 27, 38 It is conceivable that, via the induction of Zfhep or its homologues, the AT 2 receptor exerts a subtle role in the orchestration of differentiation during embryogenesis.
Interestingly, one of the clones "fished" in our differential mRNA display was the AT 2 receptor itself and the Northern blot confirmed a concordant regulation of both, AT 2 and Zfhep mRNA in PC12w cells. It furthermore confirmed a temporal transcriptional regulation of AT 2 receptors by growth factors, in our experimental set-up EGF, with a subsequent down regulation, which is in accord with the observation by other investigators for fetal calf serum, transforming growth factor-beta and bFGF. 39 The promoter of the rat AT 2 receptor contains several putative consensus sequences, such as AP-1 and AP-3, as well as a MyoD and a Myc binding site. 40 Unfortunately, the promoter sequence of Zfhep has not yet been characterized. Based on our current data, the concordant expression of Zfhep and AT 2 mRNA may be a coincidence. However, considering the overall data on expression of both genes, with a predominant expression during embryogenesis and a later restriction to select tissues or processes that involve differentiation, it is conceivable that both genes are regulated through a joint pathway.
In summary, we have identified a gene that is induced after activation of AT 2 , but not AT 1 , receptors in cells of neuronal and vascular origin. This gene encodes for a transcription factor recognized for its role in the regulation of cellular differentiation and is expressed under experimental conditions where the AT 2 receptor exerts its antiproliferative and differentiation-promoting effects. In conclusion, Zfhep not only represents a suitable marker for AT 2 receptor activation, but it may also link AT 2 signaling and downstream events involved in the proposed function of the AT 2 receptor in development and regeneration.
